+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Prednisone global market

Prednisone global market

Global Prednisone Market Research Report 2025

This report on the global prednisone market research report 2025 offers a comprehensive analysis of market size, growth drivers, emerging trends, regional performanc

Pages: 210

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Prednisone Market Report (2025–2035)

Market Outlook

Chem Reports predicts that the Prednisone Market was valued at USD xxxx million in 2024 and is expected to reach USD xxxx million by 2035, growing at a CAGR of xx% globally.

Global Market Overview

The Global Prednisone Market Report 2020 provides an extensive analysis of industry development drivers, patterns, flows, and market size. Historical and present values are assessed to forecast market performance through 2025–2035. This research integrates both primary and secondary data sources, examining:

  • Government policies and regulatory environment
  • Competitive landscape and market structure
  • Historical data and current market trends
  • Technological innovation and upcoming advancements
  • Industry progress in related sectors

Impact of COVID-19

The outbreak of COVID-19 in late 2019 disrupted global healthcare supply chains and pharmaceutical demand. The Prednisone market experienced significant challenges in 2020, with long-term effects on production, distribution, and consumption trends across anti-inflammatory therapies and other medical applications.

Market Segmentation

By Type

  • EP Quality Specification Prednisone
  • USP Quality Specification Prednisone

By Application

  • Anti-inflammatory Drug
  • Other

Regional Analysis

  • North America (U.S., Canada, Mexico): Mature market with strong demand in anti-inflammatory therapies and advanced healthcare infrastructure.
  • Europe (Germany, U.K., France, Italy, Spain, Russia): Stable demand, shaped by regulatory frameworks (EMA) and adoption in chronic disease management.
  • Asia-Pacific (China, India, Japan, Southeast Asia): Fastest-growing region, driven by expanding healthcare systems, rising pharmaceutical production, and medical exports.
  • South America (Brazil, Argentina): Emerging opportunities in hospital infrastructure and pharmaceutical packaging.
  • Middle East & Africa (Saudi Arabia, South Africa): Growing demand supported by imports and modernization of healthcare facilities.

Key Players

Additional Notable Players:

  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V. (Viatris)
  • Sanofi S.A.
  • GlaxoSmithKline plc (GSK)
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals
  • Hikma Pharmaceuticals
  • Apotex Inc.

Regional Analysis

  • North America (U.S., Canada, Mexico): Mature market with strong demand in anti-inflammatory therapies, supported by advanced healthcare infrastructure and high prevalence of autoimmune disorders.
  • Europe (Germany, U.K., France, Italy, Spain, Russia): Stable demand, shaped by EMA regulatory frameworks and adoption in chronic disease management.
  • Asia-Pacific (China, India, Japan, Southeast Asia): Fastest-growing region, driven by expanding healthcare systems, rising pharmaceutical production, and increasing prevalence of respiratory and inflammatory conditions.
  • South America (Brazil, Argentina): Emerging opportunities in hospital infrastructure and pharmaceutical distribution.
  • Middle East & Africa (Saudi Arabia, South Africa): Growing demand supported by imports and modernization of healthcare facilities.

Detailed Segmentation Analysis

By Type

  • EP Quality Specification Prednisone: European Pharmacopoeia standard, widely used in EU-regulated markets.
  • USP Quality Specification Prednisone: U.S. Pharmacopoeia standard, dominant in North America and global exports.

By Application

  • Anti-inflammatory Drug: Largest segment, covering autoimmune disorders, respiratory conditions, and chronic inflammation.
  • Other: Specialty uses in oncology, dermatology, and rare diseases.

Porter’s Five Forces

  1. Competitive Rivalry: High; global leaders (Pfizer, Teva, Novartis, Sanofi) compete with regional manufacturers.
  2. Threat of New Entrants: Moderate; barriers include regulatory approvals, GMP compliance, and distribution networks.
  3. Bargaining Power of Suppliers: Moderate; reliance on API suppliers influences costs.
  4. Bargaining Power of Buyers: High; hospitals, clinics, and healthcare systems demand cost efficiency and reliability.
  5. Threat of Substitutes: Moderate; alternatives include other corticosteroids (prednisolone, dexamethasone).

SWOT Analysis

Strengths

  • Essential corticosteroid for multiple therapeutic areas
  • Established global supply chains
  • Strong demand in chronic disease management

Weaknesses

  • Side effects limit long-term use
  • Dependence on petrochemical-based APIs
  • Regulatory hurdles and compliance costs

Opportunities

  • Expansion into Asia-Pacific and South America healthcare markets
  • Growth in generic production and exports
  • Development of controlled-release formulations to reduce side effects

Threats

  • Competition from alternative corticosteroids and biologics
  • Volatile raw material prices
  • Stringent regulatory and pharmacovigilance requirements

Trend Analysis

  • Rising demand for corticosteroids in autoimmune and respiratory conditions
  • Increasing adoption of generics in emerging markets
  • Growth in controlled-release and combination therapies
  • Technological advancements in API manufacturing and formulation

Drivers & Challenges

Drivers

  • Expanding global healthcare infrastructure
  • Rising prevalence of chronic inflammatory and autoimmune disorders
  • Technological innovation in corticosteroid formulations

Challenges

  • Environmental and regulatory pressures on pharmaceutical manufacturing
  • High production costs compared to conventional alternatives
  • Competition from biologics and targeted therapies

Value Chain Analysis

  • Upstream: API suppliers (prednisone raw material producers).
  • Midstream: Pharmaceutical manufacturers (Camphor Technologies, Shandong Taihua Bio & Tech, Sinoway Industrial, Henan Lihua, Zhejiang Xianju, Pfizer, Teva, Novartis, Sanofi, Mylan, Sun Pharma, Lupin).
  • Downstream: Hospitals, clinics, pharmacies, and healthcare providers.
  • Support Activities: Logistics, certification, regulatory compliance, R&D innovation.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in controlled-release and combination therapies to reduce side effects and improve compliance.
  • Distributors: Expand networks in Asia-Pacific and South America to capture high-growth pharmaceutical markets.
  • Investors: Focus on companies innovating in generics and corticosteroid formulations.
  • Policy Makers: Encourage broader access to affordable corticosteroids and incentivize sustainable manufacturing.
  • End-users (hospitals, healthcare providers): Diversify suppliers and adopt advanced formulations to align with patient safety and compliance goals.

Explore more reports here-

https://chemreports.com/reports

 

1. Market Overview of Prednisone
    1.1 Prednisone Market Overview
        1.1.1 Prednisone Product Scope
        1.1.2 Market Status and Outlook
    1.2 Prednisone Market Size by Regions:
    1.3 Prednisone Historic Market Size by Regions
    1.4 Prednisone Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Prednisone Sales Market by Type
    2.1 Global Prednisone Historic Market Size by Type
    2.2 Global Prednisone Forecasted Market Size by Type
    2.3 EP Quality Specification Prednisone
    2.4 USP Quality Specification Prednisone
3. Covid-19 Impact Prednisone Sales Market by Application
    3.1 Global Prednisone Historic Market Size by Application
    3.2 Global Prednisone Forecasted Market Size by Application
    3.3 Anti-inflammatory Drug
    3.4 Other
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Prednisone Production Capacity Market Share by Manufacturers
    4.2 Global Prednisone Revenue Market Share by Manufacturers
    4.3 Global Prednisone Average Price by Manufacturers
5. Company Profiles and Key Figures in Prednisone Business
    5.1 Camphor Technologies Inc
        5.1.1 Camphor Technologies Inc Company Profile
        5.1.2 Camphor Technologies Inc Prednisone Product Specification
        5.1.3 Camphor Technologies Inc Prednisone Production Capacity, Revenue, Price and Gross Margin
    5.2 Shandong Taihua Bio &Tech Co. Ltd.
        5.2.1 Shandong Taihua Bio &Tech Co. Ltd. Company Profile
        5.2.2 Shandong Taihua Bio &Tech Co. Ltd. Prednisone Product Specification
        5.2.3 Shandong Taihua Bio &Tech Co. Ltd. Prednisone Production Capacity, Revenue, Price and Gross Margin
    5.3 Sinoway Industrial Co. Ltd
        5.3.1 Sinoway Industrial Co. Ltd Company Profile
        5.3.2 Sinoway Industrial Co. Ltd Prednisone Product Specification
        5.3.3 Sinoway Industrial Co. Ltd Prednisone Production Capacity, Revenue, Price and Gross Margin
    5.4 Henan Lihua Pharmaceutical Co. Ltd.
        5.4.1 Henan Lihua Pharmaceutical Co. Ltd. Company Profile
        5.4.2 Henan Lihua Pharmaceutical Co. Ltd. Prednisone Product Specification
        5.4.3 Henan Lihua Pharmaceutical Co. Ltd. Prednisone Production Capacity, Revenue, Price and Gross Margin
    5.5 Zhejiang Xianju Xianle Pharmaceutical Co. Ltd
        5.5.1 Zhejiang Xianju Xianle Pharmaceutical Co. Ltd Company Profile
        5.5.2 Zhejiang Xianju Xianle Pharmaceutical Co. Ltd Prednisone Product Specification
        5.5.3 Zhejiang Xianju Xianle Pharmaceutical Co. Ltd Prednisone Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Prednisone Market Size
    6.2 North America Prednisone Key Players in North America
    6.3 North America Prednisone Market Size by Type
    6.4 North America Prednisone Market Size by Application
7. East Asia
    7.1 East Asia Prednisone Market Size
    7.2 East Asia Prednisone Key Players in North America
    7.3 East Asia Prednisone Market Size by Type
    7.4 East Asia Prednisone Market Size by Application
8. Europe
    8.1 Europe Prednisone Market Size
    8.2 Europe Prednisone Key Players in North America
    8.3 Europe Prednisone Market Size by Type
    8.4 Europe Prednisone Market Size by Application
9. South Asia
    9.1 South Asia Prednisone Market Size
    9.2 South Asia Prednisone Key Players in North America
    9.3 South Asia Prednisone Market Size by Type
    9.4 South Asia Prednisone Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Prednisone Market Size
    10.2 Southeast Asia Prednisone Key Players in North America
    10.3 Southeast Asia Prednisone Market Size by Type
    10.4 Southeast Asia Prednisone Market Size by Application
11. Middle East
    11.1 Middle East Prednisone Market Size
    11.2 Middle East Prednisone Key Players in North America
    11.3 Middle East Prednisone Market Size by Type
    11.4 Middle East Prednisone Market Size by Application
12. Africa
    12.1 Africa Prednisone Market Size
    12.2 Africa Prednisone Key Players in North America
    12.3 Africa Prednisone Market Size by Type
    12.4 Africa Prednisone Market Size by Application
13. Oceania
    13.1 Oceania Prednisone Market Size
    13.2 Oceania Prednisone Key Players in North America
    13.3 Oceania Prednisone Market Size by Type
    13.4 Oceania Prednisone Market Size by Application
14. South America
    14.1 South America Prednisone Market Size
    14.2 South America Prednisone Key Players in North America
    14.3 South America Prednisone Market Size by Type
    14.4 South America Prednisone Market Size by Application
15. Rest of the World
    15.1 Rest of the World Prednisone Market Size
    15.2 Rest of the World Prednisone Key Players in North America
    15.3 Rest of the World Prednisone Market Size by Type
    15.4 Rest of the World Prednisone Market Size by Application
16 Prednisone Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • EP Quality Specification Prednisone
  • USP Quality Specification Prednisone

By Application

  • Anti-inflammatory Drug
  • Other

Regional Analysis

  • North America (U.S., Canada, Mexico): Mature market with strong demand in anti-inflammatory therapies and advanced healthcare infrastructure.
  • Europe (Germany, U.K., France, Italy, Spain, Russia): Stable demand, shaped by regulatory frameworks (EMA) and adoption in chronic disease management.
  • Asia-Pacific (China, India, Japan, Southeast Asia): Fastest-growing region, driven by expanding healthcare systems, rising pharmaceutical production, and medical exports.
  • South America (Brazil, Argentina): Emerging opportunities in hospital infrastructure and pharmaceutical packaging.
  • Middle East & Africa (Saudi Arabia, South Africa): Growing demand supported by imports and modernization of healthcare facilities.

Key Players

Additional Notable Players:

  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V. (Viatris)
  • Sanofi S.A.
  • GlaxoSmithKline plc (GSK)
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals
  • Hikma Pharmaceuticals
  • Apotex Inc.

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.